Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

What is Genetic Engineering?00:49

What is Genetic Engineering?

80.6K
Overview
80.6K
CRISPR01:59

CRISPR

58.2K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.2K
Gene Therapy00:59

Gene Therapy

27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

6.9K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
6.9K
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

2.1K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
2.1K
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

16.9K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
16.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In vivo CAR T-cell generation in nonhuman primates using lentiviral vectors displaying a multidomain fusion ligand.

Blood·2024
Same author

Addendum to: Improved CRISPR genome editing using small highly active and specific engineered RNA-guided nucleases.

Nature communications·2023
Same author

A chemically inducible IL-2 receptor signaling complex allows for effective in vitro and in vivo selection of engineered CD4+ T cells.

Molecular therapy : the journal of the American Society of Gene Therapy·2023
Same author

Preclinical proof of concept for VivoVec, a lentiviral-based platform for in vivo CAR T-cell engineering.

Journal for immunotherapy of cancer·2023
Same author

Improved CRISPR genome editing using small highly active and specific engineered RNA-guided nucleases.

Nature communications·2021
Same author

Gene editing to induce FOXP3 expression in human CD4<sup>+</sup> T cells leads to a stable regulatory phenotype and function.

Science translational medicine·2020

Related Experiment Video

Updated: Feb 23, 2026

CIRCLE-Seq for Interrogation of Off-Target Gene Editing
08:23

CIRCLE-Seq for Interrogation of Off-Target Gene Editing

Published on: November 1, 2024

1.6K

Therapeutic Gene Editing Safety and Specificity.

Christopher T Lux1, Andrew M Scharenberg2

  • 1Department of Pediatrics, Cancer and Blood Disorders Center, Seattle Children's Hospital, 4800 Sand Point Way NE, Seattle, WA 98105, USA.

Hematology/Oncology Clinics of North America
|September 13, 2017
PubMed
Summary

Therapeutic gene editing offers medical advancements but requires precise tools for safety. This review covers specificity, risk mitigation, and future clinical trial considerations for gene editing technologies.

Keywords:
Gene editingGene therapyOff-targetSafetySpecific

More Related Videos

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
09:51

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

36.0K
Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice
09:00

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

8.7K

Related Experiment Videos

Last Updated: Feb 23, 2026

CIRCLE-Seq for Interrogation of Off-Target Gene Editing
08:23

CIRCLE-Seq for Interrogation of Off-Target Gene Editing

Published on: November 1, 2024

1.6K
Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
09:51

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

36.0K
Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice
09:00

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

8.7K

Area of Science:

  • Genetics
  • Molecular Biology
  • Biotechnology

Background:

  • Therapeutic gene editing is a rapidly advancing field with significant potential for treating genetic diseases.
  • Ensuring the safety and specificity of gene editing tools is paramount for clinical translation.

Purpose of the Study:

  • To review the current landscape of safety and specificity in therapeutic gene editing.
  • To identify key considerations for the design and application of gene editing technologies.
  • To foster dialogue on advancing safe and effective gene editing therapies.

Main Methods:

  • Analysis of nuclease design and DNA repair template strategies.
  • Evaluation of methods for detecting and minimizing off-target editing.
  • Review of viral vector utilization and safety profiles.

Main Results:

  • Specificity of gene editing is enhanced through rational design of nucleases and repair templates.
  • Advanced DNA repair mechanisms and novel tool generations improve sequence targeting and reduce risks.
  • Comprehensive analysis of off-target effects is crucial for safety.

Conclusions:

  • Thoughtful design, rigorous off-target analysis, and careful vector selection are essential for safe therapeutic gene editing.
  • Ongoing advancements in gene editing tools and understanding of DNA repair pathways pave the way for safer clinical applications.
  • Establishing a clear safety framework is critical for the progression of gene editing into clinical trials.